Sientra Inc (NASDAQ:SIEN)’s share price traded up 5.5% on Tuesday . The stock traded as high as $8.63 and last traded at $8.65. 27,090 shares traded hands during trading, a decline of 96% from the average session volume of 767,916 shares. The stock had previously closed at $8.20.

Several equities analysts recently weighed in on the company. BidaskClub raised Sientra from a “strong sell” rating to a “sell” rating in a research report on Thursday. Craig Hallum set a $23.00 price objective on Sientra and gave the stock a “buy” rating in a research report on Monday. Zacks Investment Research raised Sientra from a “sell” rating to a “hold” rating in a research report on Wednesday, April 17th. Wells Fargo & Co initiated coverage on Sientra in a research report on Thursday, March 14th. They set a “market perform” rating and a $9.00 price objective for the company. Finally, ValuEngine cut Sientra from a “buy” rating to a “hold” rating in a report on Thursday, March 14th. One analyst has rated the stock with a sell rating, four have issued a hold rating and seven have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $20.44.

The company has a market cap of $246.84 million, a price-to-earnings ratio of -2.65 and a beta of -0.08. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.12 and a quick ratio of 1.75.

Sientra (NASDAQ:SIEN) last released its quarterly earnings data on Tuesday, March 12th. The medical instruments supplier reported ($0.86) earnings per share for the quarter, missing the consensus estimate of ($0.67) by ($0.19). Sientra had a negative net margin of 121.28% and a negative return on equity of 123.51%. The company had revenue of $19.02 million during the quarter, compared to the consensus estimate of $18.87 million. On average, equities analysts expect that Sientra Inc will post -2.84 EPS for the current year.

Several hedge funds have recently added to or reduced their stakes in the company. Alliancebernstein L.P. grew its position in Sientra by 18.8% during the 3rd quarter. Alliancebernstein L.P. now owns 21,500 shares of the medical instruments supplier’s stock worth $513,000 after acquiring an additional 3,400 shares during the last quarter. Federated Investors Inc. PA grew its position in Sientra by 19,162.9% during the 3rd quarter. Federated Investors Inc. PA now owns 66,457 shares of the medical instruments supplier’s stock worth $1,587,000 after acquiring an additional 66,112 shares during the last quarter. AQR Capital Management LLC grew its position in Sientra by 41.5% during the 3rd quarter. AQR Capital Management LLC now owns 19,345 shares of the medical instruments supplier’s stock worth $462,000 after acquiring an additional 5,675 shares during the last quarter. Citigroup Inc. grew its position in Sientra by 101.7% during the 4th quarter. Citigroup Inc. now owns 19,000 shares of the medical instruments supplier’s stock worth $241,000 after acquiring an additional 9,579 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank bought a new stake in Sientra during the 4th quarter worth approximately $29,000. Institutional investors own 90.81% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this piece of content can be read at https://www.thecerbatgem.com/2019/04/25/sientra-sien-trading-5-5-higher.html.

Sientra Company Profile (NASDAQ:SIEN)

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.

See Also: What is Considered a Good Return on Equity (ROE)?

Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.